Atomistry » Magnesium » PDB 6vcm-6vnp » 6vno
Atomistry »
  Magnesium »
    PDB 6vcm-6vnp »
      6vno »

Magnesium in PDB 6vno: Cryo-Em Structure of the C-Terminal Half of the Parkinson'S Disease- Linked Protein Leucine Rich Repeat Kinase 2 (LRRK2)

Enzymatic activity of Cryo-Em Structure of the C-Terminal Half of the Parkinson'S Disease- Linked Protein Leucine Rich Repeat Kinase 2 (LRRK2)

All present enzymatic activity of Cryo-Em Structure of the C-Terminal Half of the Parkinson'S Disease- Linked Protein Leucine Rich Repeat Kinase 2 (LRRK2):
2.7.11.1;

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Cryo-Em Structure of the C-Terminal Half of the Parkinson'S Disease- Linked Protein Leucine Rich Repeat Kinase 2 (LRRK2) (pdb code 6vno). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Cryo-Em Structure of the C-Terminal Half of the Parkinson'S Disease- Linked Protein Leucine Rich Repeat Kinase 2 (LRRK2), PDB code: 6vno:

Magnesium binding site 1 out of 1 in 6vno

Go back to Magnesium Binding Sites List in 6vno
Magnesium binding site 1 out of 1 in the Cryo-Em Structure of the C-Terminal Half of the Parkinson'S Disease- Linked Protein Leucine Rich Repeat Kinase 2 (LRRK2)


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Cryo-Em Structure of the C-Terminal Half of the Parkinson'S Disease- Linked Protein Leucine Rich Repeat Kinase 2 (LRRK2) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg2602

b:80.8
occ:1.00
O1B A:GDP2601 2.0 76.7 1.0
OG1 A:THR1348 2.4 76.9 1.0
PB A:GDP2601 3.2 74.0 1.0
O1A A:GDP2601 3.3 94.2 1.0
CB A:THR1348 3.3 81.5 1.0
O3A A:GDP2601 3.5 81.1 1.0
PA A:GDP2601 3.6 80.4 1.0
O2A A:GDP2601 3.7 83.8 1.0
O3B A:GDP2601 4.0 76.3 1.0
CB A:ALA1396 4.1 84.8 1.0
CG2 A:THR1348 4.3 82.6 1.0
CA A:ALA1396 4.4 79.7 1.0
O2B A:GDP2601 4.4 78.6 1.0
N A:THR1348 4.4 89.7 1.0
CA A:THR1348 4.5 89.5 1.0
NZ A:LYS1347 4.5 74.0 1.0
OD2 A:ASP1394 4.7 81.6 1.0
O A:ALA1396 4.8 81.2 1.0
OD1 A:ASP1394 4.9 72.9 1.0
C A:ALA1396 5.0 80.1 1.0
CG A:LYS1347 5.0 76.6 1.0

Reference:

C.K.Deniston, J.Salogiannis, S.Mathea, D.M.Snead, I.Lahiri, M.Matyszewski, O.Donosa, R.Watanabe, J.Bohning, A.K.Shiau, S.Knapp, E.Villa, S.L.Reck-Peterson, A.E.Leschziner. Structure of LRRK2 in Parkinson'S Disease and Model For Microtubule Interaction. Nature 2020.
ISSN: ESSN 1476-4687
PubMed: 32814344
DOI: 10.1038/S41586-020-2673-2
Page generated: Tue Oct 1 22:08:33 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy